161 results
Page 3 of 9
424B5
4yvsp0
12 Dec 22
Prospectus supplement for primary offering
7:12am
8-K
EX-10.2
itiu0 i9u4x8dstpw7
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-10.1
z7rylqhivrz0n9ue2fc4
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-10.4
men402a60todmkyjg67j
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
e4ko7r 5kdtw4c32s
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
l24gwzfewv1h6i
16 Nov 22
Regulation FD Disclosure
9:24am
8-K
EX-99.1
1bzqm3
9 Nov 22
Societal CDMO Reports Third Quarter 2022 Financial Results
4:13pm
8-K
EX-10.1
smzdpbzg
16 Aug 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.1
iv3o0erohh58 v4b
10 Aug 22
Societal CDMO Reports Second Quarter 2022 Financial Results
4:13pm
SC TO-I/A
EX-99
kpb2nuejf1l97 w3d
13 Jun 22
Issuer tender offer statement (amended)
4:49pm
8-K
EX-99.1
6dxkeaoxsqgvu tnp6c
8 Jun 22
Corporate Presentation May 2022
7:35am
SC TO-I
EX-99
f1mny nkihlr
1 Jun 22
Issuer tender offer statement
5:05pm
8-K
EX-99.2
qjvjwxyw99 p80x3m0
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
6m3xjrgff2f1bz
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
dahn 7j5f3
5 May 22
Societal Cdmo Signs Three-year Manufacturing and Supply Agreement with Infectopharm for Ritalin La® In Europe
7:05am
DEFA14A
2iv2zuhxlzkhucmyqjv
1 Apr 22
Additional proxy soliciting materials
6:11pm